SubsidieMeestersRe-envisioning risk biomarkers in acute myeloid leukemia (AML) at single-cell level
The reMARK-AML project aims to refine prognostic risk parameters in NPM1-mutated acute myeloid leukemia by developing novel single-cell diagnostic assays for improved patient outcomes.
Projectdetails
Introduction
Acute myeloid leukemia (AML) is one of the most aggressive, clinically and biologically heterogeneous hematological malignancies. The different genetics classify disease entities and define the prognostic risk category to which AML patients are assigned and the treatment choices.
Disease Entities and Prognostic Factors
There is one entity, the AML with nucleophosmin (NPM1) gene mutations, that accounts for one-third of all adult AML (the most frequent). Another gene mutation - the Fms-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) - acts as the tipping point for patient risk definition. This mutation drastically worsens the prognosis and affects treatment in those 40% of patients where it is detected.
Research Focus
This has been a main field of research for Prof. Maria Paola Martelli and her team for years, specifically through her ERC consolidator grant ContraNPM1AML. Here, she will exploit concepts stemming from her ERC-funded studies on the key role of kinases in the NPM1-mutated AML development, response to therapy, and initiating relapse.
Patient Prognosis
The focus will be on the 60% of patients regarded as having a favorable prognosis, who nevertheless in 40% of cases will relapse with an extremely dismal outcome. Currently, successful strategies to identify novel frontline key markers to refine risk are not available.
Project Overview: reMARK-AML
reMARK-AML takes on the challenge of changing prognostic risk parameters, aiming to re-envision the marker at the single-cell level. A first strategy has been designed and will be tested for proof-of-concept in patients in a prospective non-interventional study.
Collaboration and Development
We have established contacts with industrial partners for the development of fit-for-purpose diagnostic assay prototypes to test in the study.
Future Challenges
The success of reMARK-AML will open the next challenge of developing marketable diagnostic kits and defining a strong business plan in order to measure the impact of our idea and proof-of-concept in the real-world clinical setting.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 150.000 |
| Totale projectbegroting | € 150.000 |
Tijdlijn
| Startdatum | 1-8-2023 |
| Einddatum | 31-1-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- UNIVERSITA DEGLI STUDI DI PERUGIApenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Mechanistic models of leukemia-niche interaction using multimodal single cell profilingThis project aims to uncover AML's interactions with the bone marrow niche through advanced single-cell sequencing and modeling, potentially transforming treatment strategies for hematological malignancies. | ERC COG | € 2.000.000 | 2022 | Details |
Decoding consequences of complex chromosomal aberrations by multi-modal single-cell deconstruction to overcome treatment-resistance cancerSHATTER-AML aims to unravel the genomic complexities of acute myeloid leukemia with complex karyotype through advanced single-cell analysis to develop targeted therapies against treatment resistance. | ERC ADG | € 2.499.375 | 2022 | Details |
Elucidating the Spatial and Temporal Dynamics of Acute Myeloid Leukemia Progression Using Functional Omics and High-Throughput In Vivo ScreeningThis project aims to explore the spatial and temporal dynamics of tumor progression in Acute Myeloid Leukemia to identify critical factors influencing cancer pathogenicity and potential therapeutic targets. | ERC COG | € 1.994.500 | 2024 | Details |
PLASTicity of Endothelial Cell as new Target for acute myeloId leukemia TherapYThis project aims to investigate embryonic-like endothelial cells in acute myeloid leukemia to identify therapeutic targets that enhance treatment responses and improve patient outcomes. | ERC STG | € 1.499.000 | 2024 | Details |
Mechanistic models of leukemia-niche interaction using multimodal single cell profiling
This project aims to uncover AML's interactions with the bone marrow niche through advanced single-cell sequencing and modeling, potentially transforming treatment strategies for hematological malignancies.
Decoding consequences of complex chromosomal aberrations by multi-modal single-cell deconstruction to overcome treatment-resistance cancer
SHATTER-AML aims to unravel the genomic complexities of acute myeloid leukemia with complex karyotype through advanced single-cell analysis to develop targeted therapies against treatment resistance.
Elucidating the Spatial and Temporal Dynamics of Acute Myeloid Leukemia Progression Using Functional Omics and High-Throughput In Vivo Screening
This project aims to explore the spatial and temporal dynamics of tumor progression in Acute Myeloid Leukemia to identify critical factors influencing cancer pathogenicity and potential therapeutic targets.
PLASTicity of Endothelial Cell as new Target for acute myeloId leukemia TherapY
This project aims to investigate embryonic-like endothelial cells in acute myeloid leukemia to identify therapeutic targets that enhance treatment responses and improve patient outcomes.